Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Medical Screening|July 31, 2015
Correction factors for self-selection when evaluating screening programmesClaudia Spix, Frank Berthold, Barbara Hero, et al.
Hamostaseologie|January 30, 2020
Health Care Transition of Adolescents and Young Adults with Haemophilia: the Situation in Germany and the Munich experienceChristoph Bidlingmaier, Martin Olivieri, Freimut H Schilling, et al.
Statistics in Medicine|September 4, 2003
Lead-time and overdiagnosis estimation in neuroblastoma screeningClaudia Spix, Jörg Michaelis, Frank Berthold, et al.
British Journal of Cancer|September 26, 2019
Correction: Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidationFrank Berthold, Angela Ernst, Barbara Hero, et al.
Cancer Letters|July 26, 2003
Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in GermanyFreimut H Schilling, Claudia Spix, Frank Berthold, et al.
British Journal of Cancer|July 12, 2018
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidationFrank Berthold, Angela Ernst, Barbara Hero, et al.
Developmental Medicine and Child Neurology|February 15, 2012
Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastomaThorsten Simon, Catherina Annika Niemann, Barbara Hero, et al.
European Journal of Pediatric Surgery Reports|August 15, 2020
Complete Resection of a Large Mediastinal Calcifying Fibrous TumorGéraldine L P Bono, Markus Lehner, Freimut H Schilling, et al.
JNCI Cancer Spectrum|July 9, 2021
Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled TrialFrank Berthold, Claudia Spix, Rudolf Erttmann, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 28, 2025
Health-Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL-QoL StudySylvia von Mackensen, Carolin Moorthi, Ronald Fischer, et al.
Pageof 3